Clinico-surgical histopathological findings of retinoblastoma cases treated at Kenyatta National Hospital by Gichigo, N et al.
December 2011 East african MEdical Journal    423
East African Medical Journal Vol. 88 No. 12 December 2011 
CLINICO-SURGICAL HISTOPATHOLOGICAL FINDINGS OF RETINOBLASTOMA CASES TREATED AT KENYATTA 
NATIONAL HOSPITAL
N, Gichigo, MBChB, MMed (Ophthalmology), ICO Ophthalmologist, Nyeri Provincial General Hospital, Nyeri, 
Kenya, M. M. Kariuki-Wanyoike, MBChB, MMed and K. Kimani, MBChB, MMed, MSc, CEH, Lecturer, Department of 
Ophthalmology, College of Health Sciences, University of Nairobi, P. O. Box 19676-00200, Nairobi, Kenya
 
Request for reprints to: Dr. N, Gichigo, P. O. Box 2360-00202, Kenyatta National Hospital, Nairobi, Kenya
CLINICO-SURGICAL HISTOPATHOLOGICAL FINDINGS OF 
RETINOBLASTOMA CASES TREATED AT KENYATTA NATIONAL HOSPITAL
N. GICHIGO, M. M. KARIUKI-WANYOIKE and K. KIMANI 
ABSTRACT
Background: Retinoblastoma is a primitive embryonal anaplastic tumour composed 
of undifferentiated retinal elements. It is the most common primary, intraocular 
malignancy of childhood. After enucleation of the diseased eye, histopathological 
findings determine the secondary management of the patient. Histopathological spread 
of the disease is a major prognostic factor on survival of the patient. 
Objectives: To determine the surgical and histopathological findings of retinoblastoma 
cases treated at the Kenyatta National Hospital between 1st January 2000 and 31st 
December 2004 and to correlate gross appearance of globe after enucleation, with 
histopathological report. 
Design: Retrospective study. 
Setting: Kenyatta National Hospital, Kenya’s largest referral and teaching hospital. 
Subject: One hundred and sixty patients with clinically diagnosed and/or hystologicaly 
confirmed retinoblastoma. 
Results: The mean duration of symptoms was ten and a half five months (SD 10.7) 
median eight months. White reflex was most common symptom in 53.3% of cases, 
orbital swelling in 39.4%, pain and redness in 15%, squint in 5% and 21.9% had other 
complaints. On examination, leucocoria was found in 38.8% of patients, enucleated 
sockets 37%, recurrent mass in the socket in 27.5%, proptosis 22.5%, orbital swelling 
in 20% while only 1.3% of patients had strabismus. Tumour was found to be grossly 
confined to the eye ball in 23.0% of operated eyes, clinically outside the eye ball in 14.3% 
of eyes while 12.4% of operated eyes had thickened optic nerves. Histologically, tumour 
was confined to the eye ball in 30% of operated eyes while tumour involved the optic 
nerve but resection margin free of tumour in 3% of eyes. Tumour had extended beyond 
the resection margin of the optic nerve in 21% of cases. Eleven point four percent had 
choroidal extension and 24% were reported as having extrascleral spread. The sensitivity 
of the surgeon’s finding at surgery, when compared to the histological findings was 
found to be 69.4% while the specificity was 69.6%. The accuracy was 69.5%. 
Conclusion: There was still late presentation of retinoblastoma in our set up that had 
been found in studies conducted previously. This was confirmed by the histological 
findings. There was inadequate documentation of surgical findings, poor record 
management and a non-comprehensive referral system.
INTRODUCTION
Retinoblastoma is a primitive embryonal anaplastic 
tumour composed of undifferentiated retinal 
elements. It is the most common primary, intraocular 
malignancy of childhood. Retinoblastoma has a 
worldwide distribution affecting all races. It accounts 
for 3% of all childhood cancers and occurs in about 
1:17,000 live births worldwide and in 1:19,000 live 
births in Kenya (1,2). No significant sex difference 
has been noted. Patients present with retinoblastoma 
within the first year of life in bilateral cases and 
around two years of age if the tumour is unilateral. 
However, 8.5% patients are children older than five 
years at initial diagnosis (3). In Kenya, majority of 
children (61.4%) were seen in the second and third 
years of life (unpublished). Majority of retinoblastoma 
patients in Kenya and other developing countries 
present late (2,4). Children with bilateral disease 
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present earlier than those with unilateral disease (5).
Retinoblastoma is unilateral in approximately 67% of 
cases and bilateral in 33% of cases (2,5-7). 
 In the developed countries, leucocoria is 
the most common presenting complaint while 
strabismus is the second most common (6). The clinical 
picture in developing countries is quite different 
because of late presentation. While most patients 
will have leucocoria as the most frequent initial 
symptom, patients present to the ophthalmologist 
with proptosis and inflammation (2,4,9). A study 
conducted in 1985 at KNH found over 90% of the 
patients presented late, only 10% were amenable to 
focal methods of treatment (2). Late presentation and 
metastatic disease are associated with poor outcomes. 
Late presentation in our setting has been attributed to 
parents’ ignorance, poor referral system and financial 
constraints (Unpublished). 
 Histopathologically, retinoblastoma consists 
of small basophilic cells with large hyperchromatic 
nuclei and scanty cytoplasm. Many tumours are 
undifferentiated but varying degrees of differentiation 
is characterised by formation of rosettes as in Flexner 
Wintersteiner rosettes, Homer-Wright rosettes and 
fleurettes. Plentiful rosettes were usually found in those 
tumours that had not extended beyond the choroid or 
as far as the resection line of the optic nerve and were, 
therefore, associated with a good prognosis. 
 In cases of early tumour detection, there is 
improved and increased use of more conservative eye 
sparing treatments. However, enucleation remains a 
frequent treatment for retinoblastoma. It is indicated 
for all unilateral tumours that fill over half of the 
eye or when there are vitreous seeding, rubeosis 
or optic nerve involvement. It is also performed if 
chemoreduction fails or a normal fellow eye makes 
aggressive chemotherapy being a poor choice for 
treatment’: It is useful for diffuse retinoblastoma 
because of poor visual prognosis and high risk of 
recurrence with other therapeutic modalities. It is the 
most common mode of treatment used in Kenyatta 
National Hospital, Nairobi (2). Due to delays in 
histopathological reporting, decision making on the 
subsequent adjuvant management of retinoblastoma 
patients (where indicated) has on occasion been based 
on gross appearance of the globe at enucleation. It is 
therefore important to compare histology reports with 
the gross appearance of the globe as a retrospective 
audit of the accuracy of our decision making process. 
MATERIALS AND METHODS  
This was a retrospective study conducted at the 
Kenyatta National Hospital, Kenya’s largest hospital. 
All patients admitted with retinoblastoma at 
Kenyatta National Hospital in the period between 1st 
January 2000 and 31st December 2004 and all records 
of patients with retinoblastoma clinically diagnosed 
and or histologically confirmed were included. All 
records of patients whose histopathological report 
ruled out retinoblastoma were excluded. Approval 
from the Kenyatta National Hospital’s Ethical Board 
was sought and obtained and patient’s records were 
treated with confidentiality. 
 All patient records of patients admitted with 
retinoblastoma in the period January 2000 to December 
2004 were retrieved. The International Disease Coding 
method was applied. Information from the socio-
biographical data sheet and or the patient cadex was 
retrieved and recorded in a questionnaire. The other 
information that was obtained from patient records 
was age at presentation, the duration of symptoms, 
laterality of disease, presenting complaint and ocular 
findings on examination. Findings at surgery were 
also recorded, it was indicated whether tumour 
was within the globe grossly, outside the globe 
and whether or not the optic nerve was thickened. 
Histopathology report where available was indicated; 
was the tumour confined to the globe, was it involving 
the optic nerve but resection margin free of tumour 
or was the margin involved, was there extrascleral 
spread and or cellular differentiation. The data were 
stored in a computer for analysis. Analysis was carried 
out using the Statistical Package for Social Scientists 
(SPSS) Version 12. 
RESULTS  
A total of 160 patients were included in 
this study. The distribution by sex, male to 
female ratio was 1.16: 1 (54 and 46% respectively). The 
distribution by bilaterality was 67% (108) for bilateral 
case and 33% (52) for unilateral cases. 




















Distribution by age at presentation 
 
 
The mean age was 35 months  SD 25, median  age  33 and  a  half  months, mode 36, and range  between 1 and 144 months. 
Table 1
Age at presentation: Age in months Vs Bilaterality n=160  
  Bilaterality







Total  108(67.5)  52(32.5 
Figure 2
Age at presentation: Age in months Vs Bilaterality n=160 
The mean age of the unilateral patients was 39.89 months compared to 24.35 months among the bilateral 
patient; the mean difference was 15.54 with a p-value of less than 0.001. 
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Other presenting complaints were: 
Loss of vision  ...........................................................................................................................................................  10 
No complaints/Routine EUA  ..................................................................................................................................  9 
Shrunken eyes  ............................................................................................................................................................  7 
Itching  .........................................................................................................................................................................  5 
Tearing/photophobia  ................................................................................................................................................4 
Table 2
Ocular Findings on Examination 
Findings  Frequency  Percentage (%)
Leucocoria 62  38.7
Enucleated  60 37.5
Recurrent Mass  44 27.5
Proptosis  36 22.5
Orbital Inflammation  32 20 
Strabismus  2 1.2
Other  10 6.2
Other ocular finding on examination: 
Phthisis  .......................................................................................................................................................................  7 
Lid swelling  ...............................................................................................................................................................  2
Nystagmus  .................................................................................................................................................................  1 
Table 3
Findings at Surgery n = 212 eyes 
Findings  Frequency  Percentage (%)
Tumour within globe grossly 50 23.6
Tumour outside clinic all  31 14.6
Thickened optic nerve  27 12.7
Inadequate Information  12 5.7
Referral with no surgical notes  47 22.2
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50 eyes (23.6%) were not operated for various reasons: 
Parent/guardian declined to consent  ..................................................................................................................  10 
Patients with bilateral disease lost to follow up after first operation  ..............................................................  17 
Patients with metastatic disease not amenable to surgery (palliative care)  .....................................................  8 
Phthisical eyes  ...........................................................................................................................................................  7 
Tumour treated with sight saving procedures (laser and EBRT)  .......................................................................  8 
Table 4
Histopathological findings 
Histology findings  Frequency  Percentage (%)
Tumour confined to eyeball  48  30
Tumour involving optic nerve but resection margin free  5  3
Tumour involving optic nerve up to resection margin  34  21
Choroidal extension  17  11.4
Extrasceral spread  39  24
Non histology report  38  23.4
Inconclusive reporting on tumour extent  13  8
Moderate cellular differentiation was reported in six of the 162 operated eyes. None of the operated 
eyes was reported as being highly differentiation. Thirteen specimen (8%) were confirmed as having 
retinoblastoma but the extent of the tumour was not reported. 
No histology report was available for 38 of the operated eyes (23.4%). Seventeen of the 162 eyes 
had choroidal extension of the tumour. 
Table 5
Histology versus surgical findings 
 Histology
At surgery  Intraocular  Etraocular  Total
Intraocular  25  10  35
Extraocular  11  23  34
Total  38  33
The sensitivity of the surgeons’ findings at surgery when compared to the histological findings was 
found to be 69.4% while the specificity was 69.6%. The positive predictive value was 71.4% while 
the negative predictive value was 67.6%. The accuracy was 69.5%. 
Figure 4
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Mean was two and a half months with a standard 
deviation of 4.2, mode was 1 month, 48% of histology 
were reported within two weeks of surgery. The 
duration ranged between three days and four 
months. 
DISCUSSION 
No significant sex differences were found in this 
study. The distribution of male to females was found 
to be 1: 1.6 which was quite similar to the ratio of 1: 
1.3 found in the study by Khan et al (1985) done in 
Kenya (unpublished). 
 The distribution by bilaterality was found to be 
67% being unilateral cases and 33% for the bilateral 
cases. This is similar to studies previously in the 
developed world (6). In Kenya, previous studies 
found the distribution to be approximately 63% being 
unilateral and 37% bilateral (2). 
 Only 15% of patients presented in the first year 
compared to 23.8 and 25% who presented in the second 
and third year respectively (Figure 1).The mean age at 
presentation were 35 months (SD 25) with a median 
age of 33 and half months and ranging from one to one 
hundred and fourty four months. These are similar 
to findings done previously in Kenyatta National 
Hospital (2). Compared to studies done in developed 
countries and even developing countries like India 
and Turkey this is very late presentation (5,7). This 
late presentation was found to be due to parents’ 
ignorance of the value of early medical intervention 
when symptoms are noted in the affected children, 
poor referral system and financial constraint that 
may have deterred parents from traveling to referral 
centres (unpublished). KNH is a national referral 
centre so the patients that present here usually will 
have been seen in one or two peripheral centres so 
time may have been lost in the referral system. The 
mean age at presentation of unilateral patients was 
39 to 89 months compared to 24  to 35 months for the 
bilateral disease and the difference was statistically 
significant (Figure 2). The bilateral patients presented 
earlier probably because they lost vision in both 
eyes and this was noted by parents and guardians 
earlier. 
 One patient presented at 12 years of age with 
a history of leueocoria for two years. Histology had 
confimed retinoblastoma with extra-scleral spread. 
Two hypotheses can be put forward to explain this 
unusual late presentation. It is possible that there 
was wrong data entry by the attending clinician on 
presentation or possibly this patient had a yet-tobe 
discovered variety retinoblastoma that is indolent 
and very slowly progressing. Nevertheless, this 
patient died within one year of presentation to the 
hospital. 
 The late presentation was also reflected in the 
clinical presentation of the disease (Figure 3 and Table 
2). Only eight of the 160 (5%) patients included in this 
study presented with early disease amenable to focal 
treatment. This presented a down ward trend from 
a study done previously in the same institution that 
found 10% of the patients being amenable to focal 
treatment (2). This apparent down ward trend was 
also reflected in the ocular examination results that 
showed 38% having leucocoria, 20% having orbital 
inflammation while 22% of patients with proptosis. 
The previous study had found 73.2, 3 and 16% 
respectively (unpublished). These results compare 
well to studies done elsewhere in Africa. In Tanzania, 
study found leucocoria in 56% of patients, proptosis in 
30%, lid swelling in 28% and strabismus in11 % (33). 
In Nigeria, study revealed proptosis with chemosis 
to be the most common presentation (9). 
 Histologically, 76.5% of enucleated eyes had 
histology (Table 4). The rest of the reports may have 
been misplaced during data storage. Some patients 
were also referred with no histology reports after 
enucleation. Only 3.7% of the cases had moderate 
differentiation, no cases were reported as highly 
differentiated while the rest all had poorly diffentiated 
tumours. This correlates with the study done in 
Uganda which found 96% of cases having poor 
differentiation (2). In total about 59% of the enucleated 
eyes had pathologic risk factors for metastasis that 
is, optic nerve invasion, choroidal invasion and 
extrascleral spread. These patients would require 
adjuvant chemotherapy or radiotherapy after the 
primary enucleation. This compares with a study 
done in India that reported 54% of 142 eyes having 
risk factors for metastasis but differs from results of a 
study done in the USA that found only 18.5% to have 
high risk for metastasis (11,12). In Uganda, found the 
risk factors in 60% of 25 eyes while the Tanzanian 
study found the factors in 45% of 36 eyes (4,10). These 
study results differs with findings in developed world 
where patients present earlier than in our set up. It is 
prudent to apply caution in analysis because of the 
missing data as mentioned earlier. Unavailability 
of histology was a challenge that was encountered 
in this study as well as the study done in Tanzania 
where only 35% of cases had histology confirmation 
(4). 
 The unavailability of histology confirmation of 
retinoblastoma in our set up is further compounded by 
long delays of reporting after enucleation. The mean 
duration was two and a half months (SD 4.2) with a 
range of three days and four months (Figure 4). This 
delay has often necessitated use of clinical diagnosis 
to commence primary and secondary treatment where 
it was needed. Clinical diagnosis of retinoblastoma, 
before primary treatment, would largely be accurate 
as retinoblastoma is the only common tumour that 
exhibits both intra-ocular and extra-ocular signs. The 
intra-operative findings at enucleation on the extent 
of tumour spread has been used to plan secondary 
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management if there was optic nerve thickeness, 
retrolaminar spread beyond resection margin or 
extrascleral spread. This study sought to compare the 
surgeon’s findings with histology report (as the gold 
standard) where they were available. The sensitivity 
was found to be 69.4% while the specificity was 69.6%. 
The accuracy was 69.5% (Table 5). 
 There were long delays between enucleation and 
histopathological reporting in this study (Figure 4). 
More than half (52%) of reporting was done more than 
two weeks after surgery and this would have resulted 
in delay in commencement of adjuvant therapy where 
indicated. In addition, it will be important in the future 
to format the histopathology reports in accordance to 
international standards of retinoblastoma reporting 
(13). 
In conclusion, there was late presentation of 
retinoblastoma cases treated at Kenyatta National 
Hospital. This is similar to the trend observed in 
studies done 15 years earlier at the same institution. 
Histopathological confirmation of retinoblastoma is 
hampered by missing reports, incomplete information 
on disease spread and long delay in reporting after 
surgery. Missing data, inadequate data entry and an 
incomprehensive referral system are challenges in the 
management of retinoblastoma in our setting. 
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